Blogs

Mini-symposia announced for San Antonio Breast Cancer Symposium®

JennyCChangChang

HelenHeslopHeslop

ElizabethMittendorfMittendorf

christopher-klebanof...Klebanoff

Immunotherapy and the inhibition of cancer cell development are the topics of the mini-symposia slated for the 42nd annual San Antonio Breast Cancer Symposium® (SABCS®) Dec. 10-14.

In “The Future of Immuno-Oncology in Breast Cancer,” speakers will discuss the latest information on immunotherapy for breast cancer treatment. Speakers in “Targeting the Cell Cycle Kinase CDK4/6 and Beyond,” will look at ways to inhibit the development of cancer cells.

Jenny C. Chang, MD of Houston Memorial Hospital, Houston and Helen Heslop, MBchB, MD, DSc of Baylor College of Medicine, Houston will moderate The Future of Immuno-Oncology in Breast Cancer, Thursday, Dec. 12 in Hall 3 at 2:15 p.m.

Speakers:

  • Elizabeth A. Mittendorf, MD, PhD of the Dana-Farber Cancer Institute, Brigham and Women’s Cancer Center, Boston will discuss enhancing response to checkpoint blockade.
  • Christopher A. Klebanoff, MD of Memorial Sloan Kettering Cancer Center, New York, will discuss T cell-based immunotherapy for a “public” neoantigen derived from a PIK3CA hotspot mutation.

AngelaDeMichele1DiMichele

SaratChandarlapaty2Chandarlapaty

rinath_jeselsohn_sog...Jeselsohn

Angela DeMichele, MD, MSCE of the Perelman School of Medicine, University of Pennsylvania, Philadelphia will moderate Targeting the Cell Cycle Kinase CDK4/6 and Beyond, Friday, Dec. 13 in Hall 3 at 2:15 p.m.

Speakers:

  • Sarat Chandarlapaty, MD, PhD of Memorial Sloan Kettering Cancer Center, New York, will discuss mechanisms of resistance to CDK4/6 inhibitors and new therapeutic approaches.
  • Rinath Jeselsohn, MD, of the Dana-Farber Cancer Institute, Susan F. Smith Center for Women’s Cancers, Boston, will discuss targeting the cell cycle beyond CDK4/6 inhibition.

Visit the following link for the complete #SABCS19 schedule. Registration for the symposium is open through Nov. 22. Visit sabcs.org to register today.

 

Categories: Program | Tags: San Antonio Breast Cancer Symposium, #SABCS19, mini-symposia, Jenny C. Chang, Helen Heslop, Elizabeth A. Mittendorf, Christopher A. Klebanoff, Angela DeMichele, Sarat Chandarlapaty, Rinath Jeselsohn, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Perelman School of Medicine, University of Pennsylvania, Baylor College of Medicine, Houston Memorial Hospital | View Count: (2943) | Return

Post a Comment